Total Payments
$12,210
2024 Payments
$2,831
Companies
62
Transactions
647
Medicare Patients
1,261
Medicare Billing
$84,339
Payment Breakdown by Category
Food & Beverage$12,012 (98.4%)
Education$198.00 (1.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,012 | 645 | 98.4% |
| Education | $198.00 | 2 | 1.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $808.93 | 43 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $786.55 | 39 | $0 (2024) |
| Merck Sharp & Dohme LLC | $693.69 | 34 | $0 (2024) |
| Amgen Inc. | $608.50 | 35 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $552.00 | 40 | $0 (2024) |
| Seagen Inc. | $532.16 | 35 | $0 (2023) |
| Genentech USA, Inc. | $483.95 | 25 | $0 (2024) |
| GENZYME CORPORATION | $441.26 | 24 | $0 (2024) |
| Daiichi Sankyo Inc. | $400.86 | 18 | $0 (2024) |
| GlaxoSmithKline, LLC. | $390.46 | 22 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,831 | 130 | PFIZER INC. ($254.97) |
| 2023 | $3,407 | 178 | E.R. Squibb & Sons, L.L.C. ($266.42) |
| 2022 | $3,043 | 169 | Merck Sharp & Dohme LLC ($306.12) |
| 2021 | $2,928 | 170 | Celgene Corporation ($234.70) |
All Payment Transactions
647 individual payment records from CMS Open Payments — Page 1 of 26
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $19.55 | General |
| 12/27/2024 | Geron Corporation | RYTELO (Drug) | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: MYELODYSPLASTIC SYNDROME | ||||||
| 12/23/2024 | Genentech USA, Inc. | Columvi (Biological), Lunsumio, Polivy | Food and Beverage | In-kind items and services | $20.15 | General |
| Category: BioOncology | ||||||
| 12/18/2024 | Genentech USA, Inc. | Tecentriq Hybreza (Biological) | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: BioOncology | ||||||
| 12/16/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), WELIREG | Food and Beverage | In-kind items and services | $23.33 | General |
| Category: ONCOLOGY | ||||||
| 12/12/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $18.80 | General |
| Category: Hematology | ||||||
| 12/10/2024 | ABBVIE INC. | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $21.33 | General |
| Category: ONCOLOGY | ||||||
| 12/09/2024 | Deciphera Pharmaceuticals Inc. | QINLOCK (Drug) | Food and Beverage | In-kind items and services | $27.96 | General |
| Category: ONCOLOGY | ||||||
| 12/02/2024 | PUMA BIOTECHNOLOGY, INC. | — | Food and Beverage | In-kind items and services | $14.52 | General |
| 11/22/2024 | Genentech USA, Inc. | Itovebi (Biological), Perjeta, Phesgo | Food and Beverage | In-kind items and services | $22.04 | General |
| Category: BioOncology | ||||||
| 11/18/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $28.17 | General |
| Category: Immunology | ||||||
| 11/14/2024 | Deciphera Pharmaceuticals Inc. | QINLOCK (Drug) | Food and Beverage | In-kind items and services | $18.83 | General |
| Category: ONCOLOGY | ||||||
| 11/13/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $20.61 | General |
| Category: Oncology | ||||||
| 11/13/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | GILOTRIF (Drug) | Food and Beverage | In-kind items and services | $15.03 | General |
| Category: ONCOLOGY | ||||||
| 11/11/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $20.90 | General |
| Category: Hematology | ||||||
| 11/08/2024 | Deciphera Pharmaceuticals Inc. | QINLOCK (Drug) | Food and Beverage | In-kind items and services | $28.68 | General |
| Category: ONCOLOGY | ||||||
| 11/08/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $21.63 | General |
| 11/06/2024 | Blueprint Medicines Corporation | AYVAKIT (Drug) | Food and Beverage | In-kind items and services | $30.43 | General |
| Category: Oncology / Rare Diseases | ||||||
| 11/04/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | GILOTRIF (Drug) | Food and Beverage | In-kind items and services | $22.12 | General |
| Category: ONCOLOGY | ||||||
| 11/01/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $32.08 | General |
| Category: ONCOLOGY | ||||||
| 10/31/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Oncology | ||||||
| 10/30/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $19.77 | General |
| Category: Immunology | ||||||
| 10/28/2024 | Novartis Pharmaceuticals Corporation | LUTATHERA (Drug) | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: Oncology | ||||||
| 10/24/2024 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $25.22 | General |
| Category: Oncology | ||||||
| 10/22/2024 | Astellas Pharma US Inc | Vyloy (Drug) | Food and Beverage | In-kind items and services | $21.50 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 59 | 61 | $6,735 | $1,628 |
| 2022 | 14 | 389 | 635 | $50,800 | $9,114 |
| 2021 | 17 | 436 | 628 | $160,742 | $29,806 |
| 2020 | 17 | 377 | 627 | $155,436 | $43,791 |
Total Patients
1,261
Total Services
1,951
Medicare Billing
$84,339
Procedure Codes
51
All Medicare Procedures & Services
51 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 18 | 18 | $4,500 | $1,283 | 28.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 21 | 22 | $660.00 | $184.80 | 28.0% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 20 | 21 | $1,575 | $159.81 | 10.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 42 | 49 | $12,250 | $3,833 | 31.3% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2022 | 15 | 23 | $11,132 | $1,935 | 17.4% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 51 | 60 | $4,500 | $625.56 | 13.9% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 62 | 78 | $5,850 | $598.22 | 10.2% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2022 | 12 | 24 | $4,320 | $451.69 | 10.5% |
| 82728 | Ferritin (blood protein) level | Office | 2022 | 23 | 23 | $1,955 | $309.12 | 15.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 25 | 31 | $2,325 | $281.09 | 12.1% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2022 | 18 | 18 | $1,386 | $267.69 | 19.3% |
| 82746 | Folic acid level, serum | Office | 2022 | 16 | 16 | $1,168 | $232.12 | 19.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 57 | 72 | $2,160 | $213.30 | 9.9% |
| 83550 | Iron binding capacity | Office | 2022 | 22 | 22 | $1,650 | $189.60 | 11.5% |
| 83540 | Iron level | Office | 2022 | 22 | 22 | $1,650 | $140.37 | 8.5% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2022 | 12 | 15 | $90.00 | $19.65 | 21.8% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2022 | 12 | 182 | $364.00 | $16.89 | 4.6% |
| J2505 | Injection, pegfilgrastim, 6 mg | Office | 2021 | 11 | 11 | $109,989 | $20,218 | 18.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 38 | 42 | $10,500 | $3,493 | 33.3% |
| 96413 | Infusion of chemotherapy into a vein up to 1 hour | Office | 2021 | 20 | 26 | $12,584 | $2,335 | 18.6% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2021 | 81 | 96 | $7,200 | $741.44 | 10.3% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour | Office | 2021 | 13 | 14 | $1,820 | $627.48 | 34.5% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2021 | 45 | 50 | $3,750 | $528.00 | 14.1% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 35 | 47 | $3,525 | $423.92 | 12.0% |
| 96367 | Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour | Office | 2021 | 11 | 17 | $2,455 | $336.09 | 13.7% |
About Deborah Graf
Deborah Graf is a Nurse Practitioner healthcare provider based in Powell, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1003992421.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Deborah Graf has received a total of $12,210 in payments from pharmaceutical and medical device companies, with $2,831 received in 2024. These payments were reported across 647 transactions from 62 companies. The most common payment nature is "Food and Beverage" ($12,012).
As a Medicare-enrolled provider, Graf has provided services to 1,261 Medicare beneficiaries, totaling 1,951 services with total Medicare billing of $84,339. Data is available for 4 years (2020–2023), covering 51 distinct procedure/service records.
Ad
Practice Information
- Specialty Nurse Practitioner
- Other Specialties Nurse Practitioner
- Location Powell, TN
- Active Since 10/27/2006
- Last Updated 11/29/2016
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1003992421
Products in Payments
- KEYTRUDA (Biological) $526.94
- OPDIVO (Biological) $479.61
- Lenvima (Drug) $383.02
- IMBRUVICA (Drug) $378.03
- LIBTAYO (Biological) $362.96
- DARZALEX (Biological) $342.21
- TUKYSA (Drug) $295.93
- VENCLEXTA (Drug) $276.98
- REBLOZYL (Biological) $267.79
- JAKAFI (Drug) $265.03
- TAGRISSO (Drug) $261.36
- Enhertu (Drug) $246.09
- CALQUENCE (Drug) $241.63
- LUMAKRAS (Drug) $239.24
- KRAZATI (Drug) $236.56
- FOTIVDA (Drug) $232.01
- TAZVERIK (Drug) $188.74
- TECVAYLI (Biological) $177.25
- ERLEADA (Drug) $177.23
- Kyprolis (Drug) $175.85
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Powell
April Bryant, Fnp, FNP
Nurse Practitioner — Payments: $16,906
Nurse Practitioner $16,906
Mrs. Misty Hammond, Fnp, FNP
Nurse Practitioner — Payments: $6,162
Nurse Practitioner $6,162
Ms. Melissa Headrick, Anp-Bc, ANP-BC
Nurse Practitioner — Payments: $5,150
Nurse Practitioner $5,150
Shannon Roberts, Np, NP
Nurse Practitioner — Payments: $4,539
Nurse Practitioner $4,539
Imelda Margulies, Aprn, APRN
Nurse Practitioner — Payments: $3,038
Nurse Practitioner $3,038
Mr. Jimmy Cox, Fnp, FNP
Nurse Practitioner — Payments: $2,433
Nurse Practitioner $2,433